Gelteq Limited Ordinary Shares
GELSGelteq Limited is a technology company specializing in the development and supply of advanced gel-based products and solutions, primarily for industrial and consumer applications. The company focuses on leveraging innovative gel formulations to deliver effective and versatile solutions across various sectors, emphasizing quality and performance.
Company News
U.S. stock futures declined on Wednesday as investors await a Supreme Court ruling on Trump's tariff authority. The Consumer Price Index rose 2.7% year-over-year in December, matching expectations, while core CPI came in slightly below forecasts at 2.6%. Major indices including the Dow Jones, S&P 500, and Nasdaq 100 all declined in premarket trad...
Gelteq Limited, a global biotechnology company, has appointed Matthew Jones as Head of Sports Performance to oversee the growth, outreach, and customer strategy of its sports vertical. Jones, a leading sports dietitian, will focus on expanding the adoption of Gelteq's gel-based delivery platform in the sports industry.
Gelteq Limited, a global biotechnology company, announced the closing of its initial public offering of 1,300,000 ordinary shares at a public offering price of US$4.00 per share. The company intends to use the net proceeds from the offering for various purposes, including funding certain manufacturing, marketing, and research and development acti...
